News

Wednesday September 26, 2018

Destiny Pharma announces appointment of Chief Medical Officer

Destiny Pharma plc (“Destiny” or “the Company”) Destiny Pharma announces appointment of Chief Medical Officer Dr Jesús González brings extensive experience in the clinical development of anti-infectives, as the Company […]

Wednesday September 26, 2018

Interim results for the 6 months ended 30 June 2018

Destiny Pharma today announced its interim results for the 6 months ended 30 June 2018, which can be found here.

Thursday September 6, 2018

Directorate Change

Destiny Pharma plc (“Destiny Pharma” or “the Company”) Directorate Change New Chairman Appointment Brighton, United Kingdom – 6 September 2018 – Destiny Pharma (AIM: DEST), a clinical stage biotechnology company […]